Avalo Therapeutics (NasdaqCM:AVTX) FY Conference Transcript

Avalo Therapeutics (NasdaqCM:AVTX) FY Conference December 02, 2025 10:30 AM ET Company ParticipantsGarry Neil - CEOConference Call ParticipantsYasmeen Rahimi - Senior Biotech AnalystYasmeen RahimiGood morning, everyone. Welcome to our Piper Sandler Healthcare Conference. My name is Yasmeen Rahimi. I'm a Senior Biotech Analyst here at Piper Sandler. Excited to have Avalo Therapeutics with us. Garry, thank you so much.Garry NeilThank you.Yasmeen RahimiObviously, it's been a great—2025 was an exciting year, bu ...